Table 1 Baseline characteristics of patients suffering from a coronary heart disease event 6–12 months ago. Comparison of self-reported high or low patient empowerment (SWE-CES-101) and general self-efficacy (GSESa)
Total n = 157 n (%), mean (SD) | SWE-CES-10 ≤ 3.6 n = 77 n (%), mean (SD) | SWE-CES-10 > 3.6 n = 72 n (%), mean (SD) | p-value | GSES ≤ 2.95 n = 48 n (%), mean (SD) | GSES > 2.95 n = 98 n (%), mean (SD) | p-value | |
|---|---|---|---|---|---|---|---|
Gender, M/F | 122/35 | 58/19 | 58/14 | 0.442 | 36/12 | 76/22 | 0.732 |
Age, years | 68.7 (8.5) | 68.4 (8.6) | 68.7 (8.4) | 0.828 | 68.7 | 68.8 | 0.919 |
Residential area | |||||||
City | 74 (47.1) | 39 (50.6) | 30 (41.7) | 24 (50.0) | 43 (43.9) | ||
Rural or small town | 83 (52.9) | 38 (49.4) | 42 (48.3) | 0.272 | 24 (50.0) | 55 (56.1) | 0.486 |
Education | |||||||
Compulsory educationb | 84 (53.5) | 40 (51.9) | 39 (54.2) | 25 (52.1) | 54 (55.1) | ||
Upper secondary school | 31 (19.7) | 14 (18.2) | 16 (22.2) | 10 (20.8) | 20 (20.4) | ||
University | 38 (24.2) | 21 (27.3) | 17 (23.6) | 0.493 | 13 (27.1) | 23 (23.5) | 0.869 |
Job position | |||||||
Employed | 26 (16.9) | 10 (13.0) | 16 (22.2) | 9 (18.8) | 15 (15.3) | ||
Self-employed | 15 (9.7) | 10 (13.0) | 5 (6.9) | 4 (8.3) | 10 (10.2) | ||
Disabled pensioner | 9 (5.8) | 6 (7.8) | 3 (4.2) | 5 (10.4) | 4 (4.1) | ||
Retired pensioner | 104 (67.5) | 50 (64.9) | 48 (66.7) | 0.295 | 30 (62.5) | 68 (69.4) | 0.531 |
Marital status | |||||||
Cohabitating | 115 (73.2) | 53 (68.8) | 59 (81.9) | 33 (68.8) | 75 (76.5) | ||
Living alone | 40 (25.5) | 24 (31.2) | 13 (18.1) | 0.064 | 15 (31.3) | 23 (23.5) | 0.314 |
Time from cardiac event to start of study group, days | 284 (74) | 274 (75) | 291 (70) | 0.147 | 277 (67) | 289 (78) | 0.362 |
Smoking, current | 19 (12.1) | 10 (13.0) | 8 (11.1) | 0.726 | 7 (14.6) | 10 (10.2) | 0.438 |
Cardiac event one year before study inclusionc | |||||||
Myocardial infarction | 86 (54.8) | 43 (55.8) | 41 (56.9) | 25 (52.1) | 56 (57.1) | ||
Other | 71 (45.2) | 34 (44.2) | 31 (43.1) | 0.892 | 23 (47.9) | 42 (42.9) | 0.563 |
Cardiac event one year before study inclusion | |||||||
PCI only | 110 (70.1) | 55 (71.4) | 50 (69.4) | 34 (70.8) | 68 (69.4) | ||
CABG, CABG+PCI or MI without revascularisation | 47(29.9) | 22 (28.6) | 22 (30.6) | 0.791 | 14 (29.2) | 30 (30.6) | 0.858 |
Number of previous myocardial infarctions | |||||||
1 | 15 (10.1) | 9 (11.7) | 6 (8.3) | 4 (8.3) | 8 (8.2) | ||
2 | 3 (2.0) | 1 (1.3) | 2 (2.8) | 2 (4.2) | 1 (1.0) | ||
3 | 2 (1.3) | 1 (1.3) | 1 (1.4) | 0.841 | 0 (0) | 2 (2.0) | 0.468 |
Angina pectoris, diagnosed | 47 (29.9) | 26 (33.8) | 19 (26.4) | 0.327 | 17 (35.4) | 28 (28.6) | 0.400 |
CCSd | |||||||
I | 98 (62.4) | 53 (75.7) | 41 (64.1) | 26(61.9) | 66 (73.3) | ||
II | 27 (17.2) | 9 (12.9) | 16 (25.0) | 9 (21.4) | 17 (18.9) | ||
III | 11 (7.0) | 6 (8.6) | 5 (7.8) | 5 (11.9) | 5 (5.6) | ||
IV | 4 (2.5) | 2 (2.9) | 2 (3.1) | 0.345 | 2 (4.8) | 2 (2.2) | 0.430 |
Diabetes Mellitus | 25 (15.9) | 9 (11.7) | 14 (19.4) | 0.190 | 11 (22.9) | 13 (13.3) | 0.139 |
Hypertension | 75 (47.8) | 37 (48.1) | 36 (50.0) | 0.812 | 26 (54.2) | 47 (48.0) | 0.481 |
Medication for hypertension before study start, days | 1376 (649–2094)e | 1542 (673–2107)e | 1270 (645–1883)e | 0.383 | 1459 (649–2149)e | 1187 (649–1912)e | 0.641 |
COPDf | 15 (9.6) | 9 (11.7) | 6 (8.3) | 0.496 | 5 (10.3) | 9 (9.2) | 0.812 |
Hyperlipidaemia | 56 (35.7) | 31 (40.3) | 24 (33.3) | 0.381 | 23 (47.9) | 29 (29.6) | 0.030 |
Days with treatment for hyperlipidaemia before study start | 1038 (420–1884)e | 695 (338–2156)e | 1150(507–1799)e | 0.513 | 1061 (341–1740)e | 1067 (456–2038)e | 0.324 |
Comorbidity, all kinds | 60 (38.2) | 26 (33.8) | 31 (43.1) | 0.244 | 16 (33.3) | 40 (40.8) | 0.382 |
Comorbidity, affecting mobility | 17 (10.8) | 10 (13.0) | 7 (9.7) | 0.531 | 6 (12.5) | 9 (9.2) | 0.535 |